We are shaping the future of medicine from the Ruhr region to Ostwestfalen-Lippe.
University Medical Center Bochum, which consists of the Faculty of Medicine and eight supporting clinics, supported by numerous teaching hospitals, we combine practical teaching, innovative research and the direct application of our findings in clinical practice. Together, we are working on the cutting-edge medicine of tomorrow - for committed students, a sustainable society and strong healthcare provision throughout the region.
The curriculum of our integrated reform medicine (iRM) degree program places particular emphasis on interdisciplinarity and practical relevance. This flexible and future-oriented education optimally prepares our students for the medical challenges of tomorrow.
Our research excels in basic research, translational science, and clinical studies, with a focus on protein sciences, oncology, and neuroscience. Following the 'From Bench to Bedside' approach, we translate laboratory findings directly into clinical applications, setting global standards.
Through the diversity of our partner hospitals and academic teaching hospitals, we position ourselves strongly in clinical education, research, and patient care. This close collaboration makes us one of the largest and most efficient university hospitals in Germany, ensuring excellent training and top-quality patient care.
More than 1,000 scientific publications and around 400 doctors trained: Ten years after the launch of the Medical Campus OWL, Ruhr University Bochum and its partners celebrate the success of their collaboration in research, teaching and regional healthcare.
How can laboratory findings lead to better diagnostics and new treatments? Neurologist Prof. Dr. Tobias Ruck combines clinical observations with molecular research, highlighting why knowledge must flow in both directions between the laboratory and patient care.
A Bochum research team has identified an enlargement of the choroid plexus in people with myotonic dystrophy for the first time. The findings offer new insights into possible disease mechanisms in the brain.
Researchers in Bochum are growing organoids from patients’ own pancreatic cancer cells to test cancer drugs. The frozen cell lines could pave the way for personalised treatments and help reduce the number of animals used in experiments.